CNE100003RP1
CNE100003RP1
SUZHOU ZELGEN BIOPHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 810.484.651 | 532.954.371 | 52.1% |
| Cost of Revenue | 77.633.817 | 36.991.446 | 109.9% |
| Gross Profit | 732.850.834 | 495.962.926 | 47.8% |
| 928.229.685 | 683.282.250 | 35.8% | |
| Operating Income | -195.378.851 | -187.319.324 | 4.3% |
| Pretax Income | -168.654.783 | -155.047.807 | 8.8% |
| Net Income Common Stockholders | -162.946.168 | -137.830.776 | 18.2% |
| -- | -- | -- | |
| -- | -- | -- |